Godavari Biorefineries Ltd

Godavari Bioref. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Godavari Biorefineries Ltd

₹ 258 -1.09%
18 Nov 9:19 a.m.
godavaribiorefineries.com BSE: 544279 NSE: GODAVARIB
About

Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]

Key Points

Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.

Website BSE NSE
  • Market Cap ₹ 1,320 Cr.
  • Current Price ₹ 258
  • High / Low ₹ 409 / 145
  • Stock P/E 28.3
  • Book Value ₹ 142
  • Dividend Yield 0.00 %
  • ROCE 5.79 %
  • ROE -3.79 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 34.9 to 27.0 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.09% over past five years.
  • Company has a low return on equity of 0.51% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Diversified FMCG Diversified FMCG

Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE IPO BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
239 398 615 523 321 447 580 533 431
271 353 501 535 354 411 467 527 439
Operating Profit -32 45 114 -12 -33 36 112 6 -8
OPM % -13% 11% 18% -2% -10% 8% 19% 1% -2%
1 2 11 3 1 4 9 1 -23
Interest 20 18 20 20 20 19 13 15 12
Depreciation 15 16 14 13 12 12 13 14 14
Profit before tax -65 13 91 -42 -64 8 96 -22 -57
Tax % -0% -201% 28% -37% 17% 32% 25% -28% -27%
-65 38 65 -26 -75 6 72 -16 -42
EPS in Rs -15.53 9.16 15.54 -6.23 -17.88 1.13 14.06 -3.13 -8.13
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
1,459 1,538 1,702 2,015 1,687 1,870 1,991
1,356 1,381 1,568 1,867 1,553 1,766 1,844
Operating Profit 103 158 134 147 134 104 146
OPM % 7% 10% 8% 7% 8% 6% 7%
14 8 6 7 14 16 -10
Interest 69 72 60 73 76 72 60
Depreciation 45 47 48 50 60 50 52
Profit before tax 3 46 32 32 12 -2 25
Tax % -24% 41% 40% 38% 1% 1,421%
4 27 19 20 12 -23 20
EPS in Rs 0.97 6.47 4.55 4.68 2.93 -4.57 3.93
Dividend Payout % -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: 3%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 1771%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -16%
Return on Equity
10 Years: %
5 Years: 2%
3 Years: 1%
Last Year: -4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 42 42 42 42 42 51 51
Reserves 385 412 431 448 459 731 674
589 569 636 736 655 490 493
418 419 625 518 836 683 246
Total Liabilities 1,434 1,442 1,734 1,744 1,992 1,955 1,463
735 708 667 866 850 862 860
CWIP 17 9 50 17 29 37 81
Investments 0 0 -0 -0 -0 -0 0
683 725 1,016 860 1,113 1,055 522
Total Assets 1,434 1,442 1,734 1,744 1,992 1,955 1,463

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
250 130 45 197 185 6
-23 -7 -48 -214 -44 -69
-226 -121 6 28 -151 64
Net Cash Flow 1 2 3 11 -10 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31 40 37 37 41 27
Inventory Days 130 146 200 137 250 195
Days Payable 123 132 176 105 195 140
Cash Conversion Cycle 39 55 61 68 95 82
Working Capital Days -68 1 3 2 -14 21
ROCE % 12% 9% 9% 7% 6%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2024Mar 2025Jun 2025Sep 2025
63.31% 63.31% 63.31% 63.31%
1.14% 0.96% 0.63% 0.60%
14.88% 14.17% 13.98% 11.98%
20.67% 21.56% 22.09% 24.11%
No. of Shareholders 1,00,68599,07896,21793,915

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls